Pharvaris N.V.
PHVS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $816,691 | $790,982 | $1,000,969 |
| - Cash | $329,286 | $199,572 | $236,496 | $280,728 |
| + Debt | $441 | $634 | $741 | $861 |
| Enterprise Value | – | $617,754 | $555,227 | $721,103 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$97 |
| % Margin | – | – | – | – |
| EBITDA | -$37,213 | -$40,270 | -$42,081 | -$35,639 |
| % Margin | – | – | – | – |
| Net Income | -$37,137 | -$45,481 | -$46,341 | -$37,079 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.6 | -0.83 | -0.85 | -0.64 |
| % Growth | 27.7% | 2.4% | -32.8% | – |
| Operating Cash Flow | -$30,669 | -$29,980 | -$38,472 | -$34,954 |
| Capital Expenditures | -$19 | $17 | -$161 | -$161 |
| Free Cash Flow | -$30,688 | -$29,964 | -$38,633 | -$35,115 |